| Patents for C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868) |
|---|
| 06/15/2005 | EP1539744A2 N-hydroxyamide derivatives possessing antibacterial activity |
| 06/15/2005 | EP1539690A2 Fluorinated monomers, fluorinated polymers having polycyclic groups with fused 4-membered heterocyclic rings, useful as photoresists, and processes for microlithography |
| 06/15/2005 | EP1137634B1 Process for the synthesis of azetidinones |
| 06/15/2005 | EP0991654B1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
| 06/09/2005 | WO2005021497A3 Tethered dimers and trimers of 1,4-diphenylazetidn-2-ones |
| 06/09/2005 | US20050124654 Compounds and methods of use |
| 06/09/2005 | US20050124598 Antibiotic compounds |
| 06/08/2005 | EP1538150A1 Novel pleuromutilin derivatives |
| 06/08/2005 | CN1205187C New amidino derivatives and their use as thrombin inhibitors |
| 06/08/2005 | CN1205184C Beta-lactan |
| 06/08/2005 | CN1205183C New amidino derivatives and their use as thrombin inhibitors |
| 06/07/2005 | US6903123 Antitussive agents, anxiolytic agents, analgesics for treating cough, anxiety and pain |
| 06/02/2005 | WO2005049594A1 N-acylsulfonamide apoptosis promoters |
| 06/02/2005 | WO2005049593A2 N-acylsulfonamide apoptosis promoters |
| 06/02/2005 | WO2005049592A1 A novel process for ezetimibe intermediate |
| 06/01/2005 | EP1534689A1 Novel carboxamide compounds having an mch-antagonistic effect, medicaments containing said compounds, and methods for the production thereof |
| 06/01/2005 | EP1461315A4 Catalytic carbonylation of three and four membered heterocycles |
| 06/01/2005 | EP1351959B1 Novel pleuromutilin derivatives |
| 05/31/2005 | US6900345 Antibiotics; mutilin 14-[N-(2-carbamoyloxyethoxycarbonyl)]carbamate; therapy for bacteria infections; chemical synthesis |
| 05/31/2005 | US6900319 Carbo- and heterocyclic amidines |
| 05/31/2005 | CA2158275C Taxanes having an amino substituted side-chain |
| 05/26/2005 | WO2005047251A1 Melanocortin receptor agonists |
| 05/26/2005 | WO2005047248A1 4-biarylyl-1-phenylazetidin-2-ones |
| 05/26/2005 | WO2005047247A1 Novel1,3-disubstituted azetidine derivatives for use as 5ht2a receptor ligands |
| 05/26/2005 | WO2005047246A1 Novel 1, 3-disubstituted azetidine deivatives for use as 5ht2a receptor ligands |
| 05/26/2005 | US20050113450 method of sterilization, sanitation, antisepsis, and disinfection, includes applying antimicrobial compounds to a surface; e.g. 2-[(3-{[4-chloro(methyl)anilino]sulfonyl}benzoyl)amino]-5-(trifluoromethyl)benzoic acid |
| 05/26/2005 | CA2545373A1 Novel 1,3-disubstituted azetidine derivatives for use as 5ht2a receptor ligands |
| 05/26/2005 | CA2545058A1 4-biarylyl-1-phenylazetidin-2-ones |
| 05/25/2005 | DE10348022A1 Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen New dipeptidyl peptidase IV inhibitors for the functional influence of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases |
| 05/24/2005 | US6897323 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same |
| 05/19/2005 | WO2005044256A1 2-azetidinones as anti-hypercholesterolemic agents |
| 05/19/2005 | WO2005044195A2 Fused phenylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 05/19/2005 | US20050107605 Novel beta-lactams methods for the preparation of taxanes, and sidechain-bearing taxanes |
| 05/19/2005 | US20050107444 E.g., 2-(3-{3-[(2-chloro-3-(trifluoromethyl)-benzyl)-(2,2-diphenylethyl)-amino]-propoxy}phenyl)-1-morpholin-4-yl-ethanone; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption |
| 05/19/2005 | CA2543943A1 2-azetidinones as anti-hypercholesterolemic agents |
| 05/19/2005 | CA2541212A1 Fused phenylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 05/18/2005 | CN1617718A N-aryl-N'-arylcycloalkyl-urea derivatives as MCH antagonists for the treatment of obesity |
| 05/18/2005 | CN1616423A E-alpha-chloro alkyllene-beta-lactan compound synthetic method and its use |
| 05/18/2005 | CN1202081C Amidino and guanidino bita-azetidinone tryptase inhibitors |
| 05/17/2005 | CA2301967C Azetidinone derivatives for the treatment of hcmv infections |
| 05/17/2005 | CA2301548C Azetidinone derivatives for the treatment of hcmv infections |
| 05/17/2005 | CA2301543C Azetidinone derivatives for the treatment of hcmv infections |
| 05/12/2005 | US20050101586 Novel 5-HT2A receptor ligands |
| 05/06/2005 | WO2004096287A3 Inosine monophosphate dehydrogenase inhibitory phosphonate compounds |
| 05/06/2005 | WO2004092116A8 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 05/05/2005 | US20050096357 Antibiotics; therapy for infections which is caused by drug-resistant Streptococcus, or bacteria infections |
| 05/04/2005 | CN1612887A Phosphino-aminophosphines |
| 04/28/2005 | WO2005037779A2 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | WO2004100888A3 N-thiolated azetidinones and anti-cancer use thereof |
| 04/28/2005 | CA2542807A1 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/27/2005 | CN1610663A Process for producing azetidinone compounds |
| 04/27/2005 | CN1198839C Novel dipeptide amidines as thrombin inhibitors |
| 04/26/2005 | CA2353981C Process for the synthesis of azetidinones |
| 04/21/2005 | WO2005035492A1 3-SUBSTITUTED β-LACTAMYL VASOPRESSIN V1A ANTAGONISTS |
| 04/21/2005 | WO2005034960A1 Treatment of diseases associated with the egr-1 enhancer element |
| 04/21/2005 | WO2005020882A3 Compound capable of binding s1p receptor and pharmaceutical use thereof |
| 04/21/2005 | CA2541590A1 Treatment of diseases associated with the egr-1 enhancer element |
| 04/14/2005 | WO2005033100A1 Novel hypocholesterolemic compounds |
| 04/14/2005 | WO2005016883A3 Acrylamide derivatives as vla-1 integrin antagonists and uses thereof |
| 04/14/2005 | US20050080078 Such as [1-(4-chloro-phenyl)-cyclobutyl]-(3-hydroxymethyl piperidin-1-yl)-methadone for treating cocaine and/or methamphetamine addiction |
| 04/14/2005 | US20050080071 Treatment methods |
| 04/14/2005 | CA2541822A1 Novel hypocholesterolemic compounds |
| 04/13/2005 | EP1522541A1 Novel hypocholesterolemic compounds |
| 04/13/2005 | EP1521742A1 Diphenylazetidinone derivatives for treating disorders of the lipid metabolism |
| 04/13/2005 | CN1196683C Amino-compound |
| 04/12/2005 | US6878833 Tetraalkylammonium alkoxides |
| 04/12/2005 | US6878732 5,7-diazaspiro(3.4)octane and -octene derivatives; treating diseases including emesis, depression, anxiety and cough |
| 04/12/2005 | US6878700 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 04/07/2005 | US20050075367 Ester compound and medicinal use thereof |
| 04/06/2005 | EP1077700B1 BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF IgE |
| 04/06/2005 | CN1604890A 取代的环己烷衍生物 Substituted cyclohexane derivatives |
| 04/06/2005 | CN1195762C Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
| 04/05/2005 | CA1341478C Therapeutic methods using catalytic antibodies |
| 03/31/2005 | US20050070719 Central nervous system disorders; antidiabetic agents; antiinflammatory agents; antiarthritic agents;obesity; osteoporosis ; anticancer agents |
| 03/31/2005 | US20050070519 Cyclisation process for the preparation of c-2 beta-lactam compounds |
| 03/30/2005 | EP1517892A1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof |
| 03/30/2005 | EP1517891A1 Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof |
| 03/30/2005 | EP1517890A1 Cationically substituted diphenyl azetidinones, method for their production, medicaments containing said compounds and use thereof |
| 03/30/2005 | CN1602206A Pharmaceutical compositions based on azetidine derivatives |
| 03/29/2005 | US6872842 Butenyl substituted taxanes |
| 03/29/2005 | US6872717 Pharmacological uses of azetidine derivatives |
| 03/24/2005 | WO2005026113A1 1, 3-disubstituted azetidine derivatives for use as ccr-3 receptor antagonists in the treatment of inflammatory and allergic diseases |
| 03/24/2005 | WO2004099132A3 Process for the preparation of trans-isomers of diphenylazetidinone derivatives |
| 03/24/2005 | US20050065211 Ester derivatives |
| 03/24/2005 | US20050065147 N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity |
| 03/24/2005 | US20050065142 Antidiabetic agents; therapy for insulin resistance |
| 03/24/2005 | CA2539049A1 Quinazoline derivatives |
| 03/23/2005 | EP1515726A1 Morpholine and tetrahydropyran derivatives and their use as cathepsin inhibitors |
| 03/16/2005 | EP1513808A2 Fluorinated cyclic amides as dipeptidyl peptidase iv inhibitors |
| 03/16/2005 | EP1513807A1 Pharmaceutical combination |
| 03/16/2005 | EP1513806A1 New salts |
| 03/16/2005 | EP1513496A1 Immediate release pharmaceutical formulation |
| 03/16/2005 | EP1513495A1 Modified release pharmaceutical formulation |
| 03/15/2005 | US6867298 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency |
| 03/15/2005 | US6867297 Process for synthesizing 4-substituted azetidinone derivatives |
| 03/15/2005 | US6867203 Cinnamide derivatives with aryl sulfide functionality; cerebral vasospasm |
| 03/10/2005 | WO2005021499A1 N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity |
| 03/10/2005 | WO2005021498A1 Lactams of alkylated acyclic diamine derivatives as modulators of chemokine receptor activity |
| 03/10/2005 | WO2005021497A2 Tethered dimers and trimers of 1,4-diphenylazetidn-2-ones |
| 03/10/2005 | WO2005020899A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity |